Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ANCN

Anchiano Therapeutics (ANCN) Stock Price, News & Analysis

Anchiano Therapeutics logo

About Anchiano Therapeutics Stock (NASDAQ:ANCN)

Advanced Chart

Key Stats

Today's Range
$1.16
$1.19
50-Day Range
$2.82
$59.00
52-Week Range
$0.51
$10.55
Volume
39,709 shs
Average Volume
3.15 million shs
Market Capitalization
$8.61 million
P/E Ratio
7.73
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ANCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anchiano Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ANCN Stock News Headlines

ITeos Therapeutics Inc Ordinary Shares
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
ENDV Endonovo Therapeutics, Inc.
See More Headlines

ANCN Stock Analysis - Frequently Asked Questions

Anchiano Therapeutics Ltd. (NASDAQ:ANCN) announced its quarterly earnings data on Monday, August, 5th. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.17) by $0.12.

Anchiano Therapeutics (ANCN) raised $35 million in an initial public offering on Tuesday, February 12th 2019. The company issued 2,400,000 shares at $14.55 per share. Oppenheimer served as the underwriter for the IPO and Ladenburg Thalmann was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Anchiano Therapeutics investors own include BioCryst Pharmaceuticals (BCRX), Bionano Genomics (BNGO), Cheniere Energy (LNG), Ocugen (OCGN), Agenus (AGEN), Allena Pharmaceuticals (ALNA) and Aileron Therapeutics (ALRN).

Company Calendar

Last Earnings
8/05/2019
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ANCN
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
7.73
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.12 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.01 per share
Price / Book
0.58

Miscellaneous

Free Float
N/A
Market Cap
$8.61 million
Optionable
Not Optionable
Beta
0.93
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ANCN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners